183 related articles for article (PubMed ID: 19275586)
1. HIV-1 mediated immune pathogenesis: spotlight on the role of viral protein R (Vpr).
Majumder B; Venkatachari NJ; Srinivasan A; Ayyavoo V
Curr HIV Res; 2009 Mar; 7(2):169-77. PubMed ID: 19275586
[TBL] [Abstract][Full Text] [Related]
2. Murine models of Vpr-mediated pathogenesis.
Snyder A; Ross MJ
Curr HIV Res; 2009 Mar; 7(2):129-35. PubMed ID: 19275581
[TBL] [Abstract][Full Text] [Related]
3. The Vpr protein from HIV-1: distinct roles along the viral life cycle.
Le Rouzic E; Benichou S
Retrovirology; 2005 Feb; 2():11. PubMed ID: 15725353
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Vpr: regulator of viral survival.
Thieu KP; Morrow MP; Shedlock DJ; Schoenly KA; Mallilankaraman K; Choo AY; Fagone P; Weiner DB; Muthumani K
Curr HIV Res; 2009 Mar; 7(2):153-62. PubMed ID: 19275584
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus viral protein R as an extracellular protein in neuropathogenesis.
Ferrucci A; Nonnemacher MR; Wigdahl B
Adv Virus Res; 2011; 81():165-99. PubMed ID: 22094081
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 viral protein R (Vpr) and its interactions with host cell.
Li G; Bukrinsky M; Zhao RY
Curr HIV Res; 2009 Mar; 7(2):178-83. PubMed ID: 19275587
[TBL] [Abstract][Full Text] [Related]
7. Macrophage signaling in HIV-1 infection.
Herbein G; Gras G; Khan KA; Abbas W
Retrovirology; 2010 Apr; 7():34. PubMed ID: 20380698
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R.
Li G; Park HU; Liang D; Zhao RY
Retrovirology; 2010 Jul; 7():59. PubMed ID: 20609246
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 Vpr: functions and molecular interactions.
Romani B; Engelbrecht S
J Gen Virol; 2009 Aug; 90(Pt 8):1795-1805. PubMed ID: 19458171
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Vpr: mechanisms of G2 arrest and apoptosis.
Andersen JL; Le Rouzic E; Planelles V
Exp Mol Pathol; 2008 Aug; 85(1):2-10. PubMed ID: 18514189
[TBL] [Abstract][Full Text] [Related]
11. Evolution of a concept: From accessory protein to key virulence factor, the case of HIV-1 Vpr.
Wallet C; Rohr O; Schwartz C
Biochem Pharmacol; 2020 Oct; 180():114128. PubMed ID: 32619426
[TBL] [Abstract][Full Text] [Related]
12. Structure-function relationship of Vpr: biological implications.
Morellet N; Roques BP; Bouaziz S
Curr HIV Res; 2009 Mar; 7(2):184-210. PubMed ID: 19275588
[TBL] [Abstract][Full Text] [Related]
13. gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.
D'Aloja P; Olivetta E; Bona R; Nappi F; Pedacchia D; Pugliese K; Ferrari G; Verani P; Federico M
J Virol; 1998 May; 72(5):4308-19. PubMed ID: 9557721
[TBL] [Abstract][Full Text] [Related]
14. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication.
Kuwata T; Igarashi T; Ido E; Jin M; Mizuno A; Chen J; Hayami M
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2181-91. PubMed ID: 7561755
[TBL] [Abstract][Full Text] [Related]
15. Vpr-host interactions during HIV-1 viral life cycle.
Zhao RY; Li G; Bukrinsky MI
J Neuroimmune Pharmacol; 2011 Jun; 6(2):216-29. PubMed ID: 21318276
[TBL] [Abstract][Full Text] [Related]
16. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?
Azad AA
Biochem Biophys Res Commun; 2000 Jan; 267(3):677-85. PubMed ID: 10673351
[TBL] [Abstract][Full Text] [Related]
17. Dual regulation of L-selectin (CD62L) by HIV-1: Enhanced expression by Vpr in contrast with cell-surface down-modulation by Nef and Vpu.
Giuliani E; Vassena L; Galardi S; Michienzi A; Desimio MG; Doria M
Virology; 2018 Oct; 523():121-128. PubMed ID: 30119013
[TBL] [Abstract][Full Text] [Related]
18. The HIV-1 Vif protein mediates degradation of Vpr and reduces Vpr-induced cell cycle arrest.
Wang J; Shackelford JM; Selliah N; Shivers DK; O'Neill E; Garcia JV; Muthumani K; Weiner D; Yu XF; Gabuzda D; Finkel TH
DNA Cell Biol; 2008 May; 27(5):267-77. PubMed ID: 18462066
[TBL] [Abstract][Full Text] [Related]
19. Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?
Ayinde D; Maudet C; Transy C; Margottin-Goguet F
Retrovirology; 2010 Apr; 7():35. PubMed ID: 20380700
[TBL] [Abstract][Full Text] [Related]
20. Vpr is preferentially targeted by CTL during HIV-1 infection.
Altfeld M; Addo MM; Eldridge RL; Yu XG; Thomas S; Khatri A; Strick D; Phillips MN; Cohen GB; Islam SA; Kalams SA; Brander C; Goulder PJ; Rosenberg ES; Walker BD;
J Immunol; 2001 Sep; 167(5):2743-52. PubMed ID: 11509618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
